U.S. Compounding Pharmacies Market (By Pharmacy Type: 503A, 503B; By Product: Oral, Liquid Preparations, Topical, Rectal, Ophthalmic, Nasal, Otic; By Sterility: Sterile, Non-Sterile; By Compounding Type: PIA, CUPM, PDA, Others; By Therapeutic Area: Hormone replacement, Pain management, Dermatology, Pediatrics, Urology, Others; By End-User: Hospitals and Clinics, Specialty Clinics, Others) - Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The U.S. compounding pharmacies market size was valued at USD 5.78 billion in 2023 and it is expected to surpass around USD 10.31 billion by 2033 with a registered CAGR of 6% from 2024 to 2033.